AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand · Delayed Price · Currency is NZD 4.810
0.00 (0.00%)
Jul 31, 2026, 4:44 PM NZST
AFT Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, AFT Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $4.65. The average 1-year stock price forecast is 3.33% lower than the current stock price, while the lowest is $4.25 (-11.64%) and the highest is $5.05 (+4.99%).
Price Target: $4.65 (-3.33%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AFT Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jarden | Jarden | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 21, 2026 |
Financial Forecast
Revenue This Year
303.82M
from 254.71M
Increased by 19.28%
Revenue Next Year
345.25M
from 303.82M
Increased by 13.64%
EPS This Year
0.19
from 0.14
Increased by 34.16%
EPS Next Year
0.24
from 0.19
Increased by 25.98%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.